BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen CC, Liou JM, Lee YC, Hong TC, El-Omar EM, Wu MS. The interplay between Helicobacter pylori and gastrointestinal microbiota. Gut Microbes 2021;13:1-22. [PMID: 33938378 DOI: 10.1080/19490976.2021.1909459] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Navashenaq JG, Shabgah AG, Banach M, Jamialahmadi T, Penson PE, Johnston TP, Sahebkar A. The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis. Semin Cancer Biol 2021:S1044-579X(21)00248-0. [PMID: 34600095 DOI: 10.1016/j.semcancer.2021.09.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 He C, Peng C, Xu X, Li N, Ouyang Y, Zhu Y, Lu N. Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota. Helicobacter. [DOI: 10.1111/hel.12898] [Reference Citation Analysis]
3 Sousa C, Ferreira R, Azevedo NF, Oleastro M, Azeredo J, Figueiredo C, Melo LDR. Helicobacter pylori infection: from standard to alternative treatment strategies. Crit Rev Microbiol 2021;:1-21. [PMID: 34569892 DOI: 10.1080/1040841X.2021.1975643] [Reference Citation Analysis]
4 Park CH. A Step Toward Discovering the New World of Esophageal Microbiota. J Neurogastroenterol Motil 2022;28:167-8. [PMID: 35362444 DOI: 10.5056/jnm22021] [Reference Citation Analysis]
5 Chen X, Wang N, Wang J, Liao B, Cheng L, Ren B. The interactions between oral-gut axis microbiota and Helicobacter pylori. Front Cell Infect Microbiol 2022;12:914418. [DOI: 10.3389/fcimb.2022.914418] [Reference Citation Analysis]
6 Hu Y, Xu X, Ouyang Y, He C, Li N, Xie C, Peng C, Zhu Z, Shu X, Xie Y, Lu N, Zhu Y. Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication. Front Cell Infect Microbiol 2022;12:881968. [DOI: 10.3389/fcimb.2022.881968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Oster P, Vaillant L, Riva E, McMillan B, Begka C, Truntzer C, Richard C, Leblond MM, Messaoudene M, Machremi E, Limagne E, Ghiringhelli F, Routy B, Verdeil G, Velin D. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Gut 2022;71:457-66. [PMID: 34253574 DOI: 10.1136/gutjnl-2020-323392] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
8 Oster P, Vaillant L, Mcmillan B, Velin D. The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection. Front Immunol 2022;13:899161. [DOI: 10.3389/fimmu.2022.899161] [Reference Citation Analysis]
9 Sulo P, Šipková B. DNA diagnostics for reliable and universal identification of Helicobacter pyloriWorld J Gastroenterol 2021; 27(41): 7100-7112 [PMID: 34887630 DOI: 10.3748/wjg.v27.i41.7100] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen B, Li X, Cai T, Wang F. Short-term and long-term alterations of gastrointestinal microbiota with different H. pylori eradication regimens: A meta-analysis. Front Cell Infect Microbiol 2022;12:913384. [DOI: 10.3389/fcimb.2022.913384] [Reference Citation Analysis]
11 Sitkin S, Lazebnik L, Avalueva E, Kononova S, Vakhitov T. Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit–risk approach? World J Gastroenterol 2022; 28(7): 766-774 [DOI: 10.3748/wjg.v28.i7.766] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Silvan JM, Guerrero-Hurtado E, Gutiérrez-Docio A, Alarcón-Cavero T, Prodanov M, Martinez-Rodriguez AJ. Olive-Leaf Extracts Modulate Inflammation and Oxidative Stress Associated with Human H. pylori Infection. Antioxidants (Basel) 2021;10:2030. [PMID: 34943133 DOI: 10.3390/antiox10122030] [Reference Citation Analysis]
13 He J, Liu Y, Ouyang Q, Li R, Li J, Chen W, Hu W, He L, Bao Q, Li P, Hu C. Helicobacter pylori and unignorable extragastric diseases: Mechanism and implications. Front Microbiol 2022;13:972777. [DOI: 10.3389/fmicb.2022.972777] [Reference Citation Analysis]
14 Abdi E, Latifi-Navid S, Abedi Sarvestani F, Esmailnejad MH. Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective. Expert Opin Ther Targets 2021;25:685-99. [PMID: 34410200 DOI: 10.1080/14728222.2021.1971195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]